Lots of bomb and Hindenburg analogies with the Exubera news. All of which were a surprise to Nektar Therapeutics, who made Exubera. Pfizer’s decision to drop the drug was communicated via press release.
Exubera fallout: Breakup by press release
Real physician voices, twice a week
Free, and one click to unsubscribe.
Keep reading
The Podcast
Latest episodes
Most popular
Hidden fees in employer health plans are about to come out
Bringing a newborn home? What hospitals don’t tell new parents
Is your clinical AI tool safe? 4 questions to ask first
Alzheimer’s treatment works best early, so why are patients waiting?
Clinical trials answer drug questions. Health questions need other tools.
Shy doctors can lead: imposter syndrome and the path to physician leadership
Fired for seeing her own patients: moral injury and life after medicine
